F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on observations, interviews and record review, the facility did not ensure timely administration of
medications for two Residents (#2 and #3) of two Residents reviewed for receipt of prescribed medications
and for two of two medication administration passes observed, resulting in thirty-one residents receiving
medications outside of the facility's medication timing parameters.
Findings Included:
1. A review of Resident #2's Medication Administration Audit Report for the month of October 2024
indicated the following:
On 10/8/24, the following medications were scheduled to be administered at 9:00 a.m. and were
documented on the Medication Administration Audit Report as administered at the following times:
Celebrex oral capsule 200 mg (milligrams), give 200 mg by mouth two times a day for moderate pain:
Documented as administered at 10:54 a.m.
Lidocaine External patch 5%, apply to lower back topically one time a day for lower back pain, remove at
2100: Documented as administered at 10:56 a.m.
Allopurinol oral tablet 300 mg, give 1 tablet by mouth one time a day for gout: Documented as administered
at 10:54 a.m.
Omeprazole oral capsule delayed release 20 mg, give 40 mg one time a day for GERD (Gastroesophageal
reflux disease.): Documented as administered at 10:54 a.m.
Digoxin oral tablet 125 mcg (micrograms), give 1 tablet by mouth one time a day for Afib (Atrial Fibrillation.):
Documented as administered at 10:54 a.m.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 6
Event ID:
105293
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105293
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Egret Cove Center
550 62nd St S
Saint Petersburg, FL 33707
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
On 10/8/24, the following medications were scheduled to be administered at 1700 hours (5:00 p.m.) and
were documented on the Medication Administration Audit Report as administered at the following times:
Level of Harm - Minimal harm
or potential for actual harm
-
Residents Affected - Some
Celebrex oral capsule 200 mg: Documented as administered at 1936 hours (7:36 p.m.)
Rivaroxaban oral tablet 20 mg, give 20 mg by mouth in the evening for Afib: Documented as administered
at 1937 hours (7:37 p.m.)
On 10/9/24, the following medications were scheduled to be administered at 2100 hours (9:00 p.m.) and
were not documented on the Medication Administration Audit Report as administered:
Xarelto Tablet (Rivaroxaban), give 5 mg by mouth at bedtime for preventative measure.
Rosuvastatin Calcium oral tablet 5 mg, give one tablet by mouth at bedtime for HLD (Hyperlipidemia)
Metoprolol Succinate oral tablet, give 75 mg by mouth at bedtime for HTN (Hypertension).
On 10/10/24, the following medications were scheduled to be administered at 1700 hours (5:00 p.m.) and
were documented on the Medication Administration Audit Report as administered at the following times:
Celebrex oral capsule 200 mg, give 200 mg by mouth two times a day for moderate pain: Documented as
administered at 0015 hours (12:15 a.m.) on 10/11/24.
Rivaroxaban oral tablet 20 mg, give 20 mg by mouth in the evening for Afib: Documented as administered
at 0021 hours (12:21 a.m.) on 10/11/24.
On 10/10/24, the following medications were scheduled to be administered at 2100 hours (9:00 p.m.) and
were documented on the Medication Administration Audit Report as administered at the following times:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105293
If continuation sheet
Page 2 of 6
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105293
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Egret Cove Center
550 62nd St S
Saint Petersburg, FL 33707
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Metoprolol Succinate 25 mg oral tablet, give 75 mg by mouth at bedtime for HTN: Documented as
administered at 0018 hours (12:18 a.m.) on 10/11/24.
Rosuvastatin Calcium oral tablet 5 mg, give one tablet by mouth at bedtime for HLD: Documented as
administered at 0016 hours (12:16 a.m.) on 10/11/24.
On 10/14/24, the following medications were scheduled to be administered at 0900 hours (9:00 a.m.) and
were documented on the Medication Administration Audit Report as administered at the following times:
Celebrex oral capsule 200 mg, give 200 mg by mouth two times a day for moderate pain: Documented as
administered at 11:05 a.m.
Lidocaine External patch 5%, apply to lower back topically one time a day for lower back pain, remove at
2100: Documented as administered at 11:06 a.m.
Allopurinol oral tablet 300 mg, give 1 tablet by mouth one time a day for gout: Documented as administered
at 10:34 a.m.
Omeprazole oral capsule delayed release 20 mg, give 40 mg one time a day for GERD: Documented as
administered at 11:05 a.m.
Digoxin oral tablet 125 mcg, give 1 tablet by mouth one time a day for Afib: Documented as administered at
10:34 a.m.
Spironolactone oral tablet 25 mg, give 1 tablet by mouth one time a day every Mon, Wed and Fri for HTN:
Documented as administered at 10:34 a.m.
A review of Resident #2's Progress Notes for the month of October 2024 did not include notification to the
resident's primary physician regarding late administration of medication.
(Photographic Evidence Obtained)
2. On 12/2/24 at 11:00 a.m., an observation and interview were conducted in the 400 hallways with Staff A,
Registered Nurse/Unit Manager (RN/UM) during medication administration. An observation was
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105293
If continuation sheet
Page 3 of 6
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105293
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Egret Cove Center
550 62nd St S
Saint Petersburg, FL 33707
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
made of Staff A, RN/UM's computer screen, which was showing the Medication Administration Record
(MAR) for her assigned residents during the Day (7:00 a.m. to 3:00 p.m.) shift. The MAR showed 15
residents requiring their morning medications and all the residents were shown in red, indicating the
medications were late. Staff A, RN/UM agreed medications were late for these residents. Staff A, RN/UM
stated she arrived at the facility at her usual time of 8:30 a.m., and was unaware there was a sick call on
her side of the facility. Staff A, RN/UM stated this was the reason her medications were late this morning.
(Photographic Evidence Obtained)
On 12/2/24 at 3:00 p.m., an interview was conducted with Staff B, Licensed Practical Nurse/Unit Manager
(LPN/UM). Staff B, LPN/UM stated medications have a window of one hour before and one hour after the
ordered medication time to consider medication on time. Staff B, LPN/UM denied the facility had liberalized
medication administration times.
On 12/03/24 10:32 a.m., an observation and interview were conducted in the 200 hallways with Staff C,
RN, during medication administration. An observation was made of Staff C, RN's computer screen, which
was showing the MAR for her assigned residents during the Day shift. The MAR showed with 16 residents
requiring their morning medications and all the residents were shown in red, indicating the medications
were late. Staff C, RN agreed medications were late for these residents. Staff C, RN stated she normally
works the night shift and was having difficulty in locating missing medications, which would normally be in
the bottom drawer of the medication cart. Staff B, LPN/UM arrived during the interview and stated he would
be assisting Staff C, RN with the remainder of Staff C's medication administration.
On 12/3/24 at 10:55 a.m., an interview was conducted with the Director of Nursing (DON) and the Assistant
Director of Nursing (ADON). Both the DON and ADON were aware of the late medication administration on
12/2/24 and 12/3/24. The ADON stated Staff C, RN normally works the night shift and may be struggling
with the day shifts higher demand of medication administration. The DON stated the pharmacy has a
process where automatic renewal should be implemented, and staff can request and/or a par is created by
pharmacy to automatically dispense the medication. The DON could not explain why medications were late
on 12/3/24.
On 12/3/24 at 11:20 a.m., an observation and interview were conducted with Staff B, LPN/UM at med cart
1 pulling medications to assist Staff C, RN. Staff B, LPN/UM stated he was pulling the medications for the
residents and Staff C, RN was distributing them to the residents. Staff B, LPN/UM stated the electronic
chart was logged in under Staff C, RN's name, but would not state who was documenting in the MAR.
On 12/3/24 at 11:30 a.m., an interview was conducted with the DON. The DON stated medication
administration should be conducted with one nurse pulling the medication, administering the medication,
and documenting the medication. If two nurses are administering from the same cart, an extra computer
should be available, or the screen could be split and logged under each nurse individually.
On 12/3/24 at 12:20 p.m., an interview was conducted with the ADON. The ADON stated the Medical
Director was notified of all the late medication administration for 12/3/24, but the individual physicians for
the residents had not. The DON stated the individual physicians will be notified for the late medications for
12/3/24 as well as the late medications from 12/2/24.
A review of Resident #3's Medication Administration Audit Report for the month of October 2024 showed
medications were administered late on the following dates and times:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105293
If continuation sheet
Page 4 of 6
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105293
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Egret Cove Center
550 62nd St S
Saint Petersburg, FL 33707
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
-
Level of Harm - Minimal harm
or potential for actual harm
10/7/24: four medications during the 4:00 p.m., 4:30 p.m., and 5:00 p.m. medication passes.
-
Residents Affected - Some
10/8/24: 19 medications during the 9:00 a.m., 4:30 p.m., 5:00 p.m., and 9:00 p.m. medication passes.
10/9/24: three medications were scheduled to be administered at 9:00 p.m. and were not administered.
10/10/24: 10 medications during the 11:30 a.m., 4:00 p.m., 4:30 p.m., 5:00 p.m., and 9:00 p.m. medication
passes.
10/13/24: four medications during the 4:00 p.m., 4:30 p.m., and 5:00 p.m. medication passes.
10/14/24: 14 medications during the 9:00 a.m. medication pass.
10/18/24: 19 medications during the 9:00 a.m., 4:00 p.m., 4:30 p.m., 5:00 p.m., and 9:00 p.m. medication
passes.
10/21/24: 15 medications during the 9:00 a.m., 11:00 a.m., and 1:00 p.m. medication passes.
10/22/24: 16 medications during the 7:00 a.m., 9:00 a.m., and 11:00 a.m. medication passes.
A review of Resident #3's Progress Notes for the month of October 2024 did not include notification to the
resident's primary physician regarding late administration of medications. (Photographic Evidence
Obtained)
An interview was conducted with the DON, ADON, and Regional Nurse, on 12/3/24 at 5:10 p.m. regarding
the late medications for Residents #2 and #3 for October 2024. There was no explanation provided as to
why the medications were administered late on the specific dates.
A review of the facility's policy and procedure titled, Medication Administration General
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105293
If continuation sheet
Page 5 of 6
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105293
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Egret Cove Center
550 62nd St S
Saint Petersburg, FL 33707
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Guidelines, dated 9/2018 showed the following procedures under the section titled, Medication
Administration, to include but not limited to:
3. Medication administration timing parameters include the following:
a. Medications to be given on an empty stomach or before meals are not to be scheduled for administration
30 minutes to two hours prior to meals.
b. Medications to be given with meals are to be scheduled for administration at the resident's mealtimes.
c. Medications to be given after meals or with food are to be scheduled for administration immediately after
and up to two hours after meals or with a snack .
d. Medications to be given at bedtime are to be scheduled for administration up to one hour prior to the
resident's scheduled bedtime.
.
5. The person who prepares the dose for administration is the person who administers the dose.
.
14. Medications are administered within 60 minutes of scheduled time, except before or after meal orders,
which are administered based on mealtimes. Unless otherwise specified by the prescriber, routine
medications are administered according to the established medication administration schedule for the
nursing care center. Medications should not be given at mealtime or in the dining room unless specifically
ordered with meal.
The policy and procedure also revealed the following under the section titled, Documentation:
1. The individual who administers the medication dose records the administration on the residents MAR
immediately following the medication being given. In no case should the individual who administered the
medication report off duty without first recording the administration of any medications.
A review of the facility's policy titled Physician Notification, effective October 2021, showed the following
policy statement: The facility strives to ensure each resident's health is supervised by a qualified attending
physician. The attending physician in the facility is ultimately responsible for supervision and management
of the care of the resident/patient. A review of this policy's Procedure showed:
1. Licensed Nurses will ensure the physicians are notified of changes or diagnostic results that occur
between visits. Changes may include but are not limited to:
- Any time a medication is not administered as ordered.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105293
If continuation sheet
Page 6 of 6